Affymetrix Offers a Glimpse into its Future At Lehman Brothers Healthcare Conference | GenomeWeb

Affymetrix is experimenting with a format for manufacturing its microarrays that will allow the company to cut 6,400 chips out of a wafer, Greg Schiffman, the Santa Clara, Calif.-based company's chief financial officer, said last week at the Lehman Brothers Healthcare conference in Miami Beach, Fla.

Today, the company manufacturers just 49 chips to a wafer, the blank of quartz that it uses as the surface foundation on which to build its DNA probes via photolithography.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.